Uso de rifabutina en casos de toxicidad a rifampicina / Use of rifabutin in cases of toxicity to rifampicin
Rev. clín. esp. (Ed. impr.)
; 205(9): 430-432, sept. 2005. tab
Article
in Es
| IBECS
| ID: ibc-040882
Responsible library:
ES1.1
Localization: ES1.1 - BNCS
RESUMEN
La rifampicina es un fármaco esencial en el tratamiento actual de la tuberculosis. En algunas ocasiones no se puede utilizar por efectos adversos graves. La rifabutina es un fármaco de la misma familia, con una actividad similar y efectos adversos diferentes. En este estudio se describen los resultados beneficiosos de la sustitución de rifampicina por rifabutina en pacientes con toxicidad intensa (AU)
ABSTRACT
Rifampicin is an essential drug in the present treatment of tuberculosis. On some occasions, it cannot be used due to severe adverse effects. Rifabutin is a drug of the same family, with a similar activity and difference adverse effects. This study describes the beneficial results of the substitution of rifampicin with rifabutin in patients with severe toxicity (AU)
Search on Google
Collection:
National databases
/
Spain
Health context:
Neglected Diseases
Health problem:
Neglected Diseases
/
Tuberculosis
Database:
IBECS
Main subject:
Rifampin
/
Tuberculosis, Pulmonary
/
Rifabutin
Type of study:
Observational study
/
Risk factors
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Rev. clín. esp. (Ed. impr.)
Year:
2005
Document type:
Article
Institution/Affiliation country:
Hospital Cantoblanco-HGUGM/España
/
Medicina Familiar y Salud Comunitaria/España